The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,310.00
Bid: 4,305.00
Ask: 4,325.00
Change: 55.00 (1.29%)
Spread: 20.00 (0.465%)
Open: 4,250.00
High: 4,330.00
Low: 4,245.00
Prev. Close: 4,255.00
CWK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Mar 2018 07:00

RNS Number : 6120G
Cranswick PLC
05 March 2018
 

5 March 2018

Cranswick plc("Cranswick" or "the Company" or "the Group")

Directorate changes

Cranswick plc announces the appointment, with effect from 1 April 2018, of Pam Powell and Tim Smith as independent non-executive directors of the Company.

Pam Powell

Pam has a long and successful international career in strategy, marketing and innovation in fast moving consumer goods, including latterly, food and beverages. Pam spent nine years at SABMiller plc, holding the position of Group Director of Strategy and Innovation, and prior to this, worked at Coty Europe in France, Unilever plc in London, and Lever Brothers in New York.

Pam is currently a non-executive director of Premier Foods plc and A.G. Barr plc. No other information on Pam is required to be disclosed pursuant to Listing Rule 9.6.13R.

Tim Smith

Tim has extensive experience of the UK food sector having worked in food manufacturing, government regulation and supermarket retail during his career.

Most recently, Tim worked at Tesco plc between 2012 and 2017 as its Group Quality Director where he was responsible for product development, responsible sourcing, quality and technical matters. Prior to joining Tesco, Tim was the Chief Executive of the Food Standards Agency between 2008 and 2012 during which time he led a strategic review of the agency and also developed strong relationships with regulatory organisations and government in the UK and the rest of the world. Before joining the Food Standards Agency, Tim led a number of food manufacturing businesses including Express Dairies plc and Arla Foods plc where Tim became Chief Executive in 2005 with responsibility for delivery of the group's strategic plan including a £180million investment programme. Tim also sits on the board of a number of food industry and charitable bodies.

No other information on Tim is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Martin Davey, Chairman of Cranswick plc, commented:

"I am delighted that Pam and Tim will be joining our board. They bring significant additional expertise and sector experience which the Group will benefit from as it continues to move forward and develop."

 

 

For further information, please contact:

Enquiries:

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

 

 

 

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2017 showed revenue from continuing operations of £1,245m and profit before tax on the same basis of £77.5m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUSUBRWAAORAR
Date   Source Headline
13th Jul 20211:45 pmRNSANNUAL GENERAL MEETING 2021 – UPDATE
12th Jul 20213:46 pmRNSHolding(s) in Company
1st Jul 20218:59 amRNSTotal Voting Rights
24th Jun 20219:00 amRNSHolding(s) in Company
18th Jun 20212:24 pmRNSHolding(s) in Company
1st Jun 20212:35 pmRNSDirector/PDMR Shareholding
1st Jun 20212:25 pmRNSTotal Voting Rights
1st Jun 20212:24 pmRNSDirector/PDMR Shareholding
21st May 202111:00 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
20th May 202112:08 pmRNSDirector/PDMR Shareholding
20th May 202112:06 pmRNSDirector/PDMR Shareholding
20th May 202112:03 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company
3rd Nov 20205:15 pmRNSTotal Voting Rights
27th Oct 20202:55 pmRNSHolding(s) in Company
27th Oct 20202:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.